Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth

15Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Reprogramming of amino acid metabolism, sustained by oncogenic signaling, is crucial for cancer cell survival under nutrient limitation. Here we discovered that missense mutant p53 oncoproteins stimulate de novo serine/glycine synthesis and essential amino acids intake, promoting breast cancer growth. Mechanistically, mutant p53, unlike the wild-type counterpart, induces the expression of serine-synthesis-pathway enzymes and L-type amino acid transporter 1 (LAT1)/CD98 heavy chain heterodimer. This effect is exacerbated by amino acid shortage, representing a mutant p53-dependent metabolic adaptive response. When cells suffer amino acids scarcity, mutant p53 protein is stabilized and induces metabolic alterations and an amino acid transcriptional program that sustain cancer cell proliferation. In patient-derived tumor organoids, pharmacological targeting of either serine-synthesis-pathway and LAT1-mediated transport synergizes with amino acid shortage in blunting mutant p53-dependent growth. These findings reveal vulnerabilities potentially exploitable for tackling breast tumors bearing missense TP53 mutations.

Cite

CITATION STYLE

APA

Tombari, C., Zannini, A., Bertolio, R., Pedretti, S., Audano, M., Triboli, L., … Del Sal, G. (2023). Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth. Nature Communications, 14(1). https://doi.org/10.1038/s41467-023-42458-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free